Cargando…

Somatic Versus Cognitive Depressive Symptoms as Predictors of Coronary Artery Disease among Women with Suspected Ischemia: The Women’s Ischemia Syndrome Evaluation

BACKGROUND: Depression is an established predictor of coronary artery disease (CAD) progression and mortality. “Somatic” symptoms of depression such as fatigue and sleep impairment overlap with symptoms of CAD and independently predict CAD events. Differentiating between “somatic” and “cognitive” de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Emami, Ashley S., Bairey Merz, C. Noel, Eastwood, Jo-Ann, Pepine, Carl J., Handberg, Eileen M., Bittner, Vera, Mehta, Puja K., Krantz, David S., Vaccarino, Viola, Eteiba, Wafia, Cornell, Carol E., Rutledge, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713564/ https://www.ncbi.nlm.nih.gov/pubmed/34966880 http://dx.doi.org/10.4103/hm.hm_34_21

Ejemplares similares

Depression Symptom Patterns as Predictors of Metabolic Syndrome and Cardiac Events in Symptomatic Women with Suspected Myocardial Ischemia: The Women’s Ischemia Syndrome Evaluation (WISE and WISE-CVD) Projects
por: Virzi, Nicole E., et al.
Publicado: (2022)

Symptom Presentation among Women with Suspected Ischemia and No Obstructive Coronary Artery Disease (INOCA)
por: Taha, Yasmeen K., et al.
Publicado: (2023)

Sudden Cardiac Death in Women With Suspected Ischemic Heart Disease, Preserved Ejection Fraction, and No Obstructive Coronary Artery Disease: A Report From the Women's Ischemia Syndrome Evaluation Study
por: Mehta, Puja K., et al.
Publicado: (2017)

Weight cycling and cardiovascular outcome in women with suspected ischemia: A report from the NHLBI-sponsored WISE Study
por: Bairey Merz, C. Noel, et al.
Publicado: (2018)

Predicted Versus Observed Major Adverse Cardiac Event Risk in Women With Evidence of Ischemia and No Obstructive Coronary Artery Disease: A Report From WISE (Women's Ischemia Syndrome Evaluation)
por: Sedlak, Tara, et al.
Publicado: (2020)

Renal Function and Coronary Microvascular Dysfunction in Women with Symptoms/Signs of Ischemia
por: Mohandas, Rajesh, et al.
Publicado: (2015)

Ischemia and No Obstructive Coronary Artery Disease (INOCA): What Is the Risk?
por: Herscovici, Romana, et al.
Publicado: (2018)

Brachial Artery Constriction during Brachial Artery Reactivity Testing Predicts Major Adverse Clinical Outcomes in Women with Suspected Myocardial Ischemia: Results from the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study
por: Sedlak, Tara L., et al.
Publicado: (2013)

TIMI Frame Count and Adverse Events in Women with No Obstructive Coronary Disease: A Pilot Study from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE)
por: Petersen, John W., et al.
Publicado: (2014)

Angina Hospitalization Rates in Women With Signs and Symptoms of Ischemia But no Obstructive Coronary Artery Disease: A Report from the WISE (Women's Ischemia Syndrome Evaluation) Study
por: Aldiwani, Haider, et al.
Publicado: (2020)

Coronary endothelial dysfunction appears to be a manifestation of a systemic process: A report from the Women’s Ischemia Syndrome Evaluation – Coronary Vascular Dysfunction (WISE-CVD) study
por: Jalnapurkar, Sawan, et al.
Publicado: (2021)

Cardiovascular and Mortality Risk of Apparent Resistant Hypertension in Women With Suspected Myocardial Ischemia: A Report From the NHLBI‐Sponsored WISE Study
por: Smith, Steven M., et al.
Publicado: (2014)

Number and Function of Bone-Marrow Derived Angiogenic Cells and Coronary Flow Reserve in Women without Obstructive Coronary Artery Disease: A Substudy of the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE)
por: Mohandas, Rajesh, et al.
Publicado: (2013)

Five-year stroke rate in women with signs and symptoms of ischemia undergoing coronary angiography: a retrospective study from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE)
por: Haftbaradaran, A, et al.
Publicado: (2015)

Relationship between coronary function testing and migraine: results from the Women’s Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction project
por: Siak, Jessica, et al.
Publicado: (2021)

Prevalence of Coronary Endothelial and Microvascular Dysfunction in Women with Symptoms of Ischemia and No Obstructive Coronary Artery Disease Is Confirmed by a New Cohort: The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation–Coronary Vascular Dysfunction (WISE-CVD)
por: Anderson, R. David, et al.
Publicado: (2019)

N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women’s Ischemia Syndrome Evaluation–Coronary Vascular Dysfunction (WISE-CVD) study
por: Jones, Erika, et al.
Publicado: (2020)

Effectiveness of cardioprotective medication in women with suspected ischemic heart disease syndrome: the NHLBI-sponsored women's ischemia synrome evaluation (WISE) study
por: Doyle, Mark, et al.
Publicado: (2011)

Oxidative Stress Is Associated With Diastolic Dysfunction in Women With Ischemia With No Obstructive Coronary Artery Disease
por: Raad, Mohamad, et al.
Publicado: (2020)

Autoimmune rheumatic diseases in women with coronary microvascular dysfunction: a report from the Women's Ischemia Syndrome Evaluation—Coronary Vascular Dysfunction (WISE-CVD) project
por: Chen, Melanie T., et al.
Publicado: (2023)

Adrenergic gene polymorphisms and cardiovascular risk in the NHLBI-sponsored Women's Ischemia Syndrome Evaluation
por: Pacanowski, Michael A, et al.
Publicado: (2008)

Inflammatory biomarkers as predictors of heart failure in women without obstructive coronary artery disease: A report from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE)
por: AlBadri, Ahmed, et al.
Publicado: (2017)

Ultra-high sensitivity cardiac troponin-I concentration and left ventricular structure and function in women with ischemia and no obstructive coronary artery disease
por: Quesada, Odayme, et al.
Publicado: (2022)

Not typical angina and mortality in women with obstructive coronary artery disease: Results from the Women’s Ischemic Syndrome Evaluation study (WISE)
por: Jones, Erika, et al.
Publicado: (2020)

Trans-myocardial omega-3 fatty acid gradient in coronary microvascular dysfunction
por: Keeley, Ellen C., et al.
Publicado: (2022)

Phosphodiesterase type 5 inhibition may reduce diastolic function in women with ischemia but no obstructive coronary artery disease
por: Nelson, Michael D., et al.
Publicado: (2017)

Mental Stress-Induced Myocardial Ischemia
por: Mehta, Puja K., et al.
Publicado: (2022)

Body weight and physical fitness in women with ischaemic heart disease: does physical fitness contribute to our understanding of the obesity paradox in women?
por: Quesada, Odayme, et al.
Publicado: (2022)

Age at Menarche and Risk of Cardiovascular Disease Outcomes: Findings From the National Heart Lung and Blood Institute‐Sponsored Women's Ischemia Syndrome Evaluation
por: Lee, Julie J., et al.
Publicado: (2019)

Mental Stress and Myocardial Ischemia: Young Women at Risk
por: Wokhlu, Anita, et al.
Publicado: (2016)

Cold Pressor Stress Cardiac Magnetic Resonance Myocardial Flow Reserve Is Not Useful for Detection of Coronary Endothelial Dysfunction in Women with Signs and Symptoms of Ischemia and No Obstructive CAD
por: Landes, Sofy, et al.
Publicado: (2017)

Migraine Headache: An Under‐Appreciated Risk Factor for Cardiovascular Disease in Women
por: Elgendy, Islam Y., et al.
Publicado: (2019)

Fitness attenuates long-term cardiovascular outcomes in women with ischemic heart disease and metabolic syndrome
por: Quesada, Odayme, et al.
Publicado: (2023)

Case report: Repeat coronary function testing in women with ischemia and no obstructive coronary artery disease
por: Suppogu, Nissi, et al.
Publicado: (2023)

Left ventricular mass and myocardial scarring in women with hypertensive disorders of pregnancy
por: Quesada, Odayme, et al.
Publicado: (2020)

Temporal Trends in Angina, Myocardial Perfusion, and Left Ventricular Remodeling in Women With No Obstructive Coronary Artery Disease Over 1‐Year Follow‐Up: Results From WISE‐CVD
por: Quesada, Odayme, et al.
Publicado: (2020)

Bio-informatics assessment schema (BIAS) to improve myocardial perfusion image diagnostic and prognostic value: the NHLBI-sponsored women's ischemia syndrome evaluation (WISE) study
por: Doyle, Mark, et al.
Publicado: (2014)

SAT-LB99 Inflammation May Mediate Coronary Artery Disease in Women With Hypothalamic Hypoestrogenemia: Findings From the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE)
por: Torbati, Tina, et al.
Publicado: (2020)

Left atrial stiffness in women with ischemia and no obstructive coronary artery disease: Novel insight from left atrial feature tracking
por: Zamani, Sauyeh K., et al.
Publicado: (2020)

Subclinical systolic and diastolic dysfunction in women with signs and symptoms of ischemia but no obstructive coronary disease: novel insights using myocardial feature tracking in the NHLBI WISE study
por: Nelson, Michael D, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4rmdi81snlt4d3l7jvdr6k31tn